CD274 and neoplasm: However, as shown in mouse models and in cancer patients, immunogenic tumor PD-L1 expression is heterogeneous (76) and transient (75), which does not support the idea that tumor-derived PD-L1 expression is required for tolerance induction and maintenance or that PD-L1+ tumor clones are preferably selected during tumorigenesis.